Cargando…

Antigenic imprinting in SARS‐CoV‐2

Detalles Bibliográficos
Autores principales:	Reincke, S. Momsen, Prüss, Harald, Wilson, Ian A., Kreye, Jakob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270639/ https://www.ncbi.nlm.nih.gov/pubmed/35808842 http://dx.doi.org/10.1002/ctm2.923

Ejemplares similares

Do cross-reactive antibodies cause neuropathology in COVID-19?
por: Kreye, Jakob, et al.
Publicado: (2020)

Brain antibody sequence evaluation (BASE): an easy-to-use software for complete data analysis in single cell immunoglobulin cloning
por: Reincke, S. Momsen, et al.
Publicado: (2020)

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
por: Yuan, Meng, et al.
Publicado: (2021)

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
por: Yuan, Meng, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics
por: Ly, Lam-Thanh, et al.
Publicado: (2018)

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
por: Kreye, Jakob, et al.
Publicado: (2023)

Brain blood vessel autoantibodies in patients with NMDA and GABA(A) receptor encephalitis: identification of unconventional Myosin-X as target antigen
por: Li, Lucie Y., et al.
Publicado: (2023)

Abrupt decreases in infectivity of SARS-CoV-2 in aerosols
por: Löndahl, Jakob, et al.
Publicado: (2022)

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Pediatric de novo movement disorders and ataxia in the context of SARS-CoV-2
por: Wilpert, Nina-Maria, et al.
Publicado: (2023)

SARS-CoV-2 vaccination in the context of original antigenic sin
por: Petráš, Marek, et al.
Publicado: (2021)

Implementing digital passports for SARS-CoV-2 immunization in Canada
por: Wilson, Kumanan, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response
por: Zhang, Ying, et al.
Publicado: (2021)

Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2
por: Sexton, Mary Elizabeth, et al.
Publicado: (2021)

SARS CoV-2 load in periodontal disease
por: Sahni, Vaibhav
Publicado: (2022)

In SARS-CoV-2, astrocytes are in it for the long haul
por: Huang, Shuhan, et al.
Publicado: (2022)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

Mitigating airborne transmission of SARS-CoV-2
por: Addleman, Sarah, et al.
Publicado: (2021)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model
por: Kreye, Jakob, et al.
Publicado: (2020)

Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care
por: Bulilete, Oana, et al.
Publicado: (2021)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

The Role of Antibody Testing for SARS-CoV-2: Is There One?
por: Theel, Elitza S., et al.
Publicado: (2020)

SARS-CoV-2 and human reproduction: An open question
por: Entezami, Frida, et al.
Publicado: (2020)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i9ki14ghm2ek8odgv6ii9g6ijb